How to Find Better Treatments for Rare Childhood Brain Tumors

Brain tumors are the leading cause of cancer-related death among children in the U.S. And many pediatric brain tumors are so rare that no single hospital sees enough patients to answer critical questions or test promising treatments quickly.

UC San Francisco pediatric neuro-oncologists Sabine Mueller , MD, PhD, and Michael Prados , MD, wanted to change that. In 2012, after decades of limited progress against some of the most difficult-to-treat childhood brain tumors, they founded PNOC to bring researchers and institutions together to help accelerate the search for better treatments.

What began with six institutions has grown into a network of nearly 300 pediatric brain tumor specialists at 43 centers around the world. Together, PNOC researchers have conducted 40 clinical trials involving more than 1,400 pediatric patients.

Today, PNOC is leading international clinical trials - including work funded by the National Institutes of Health (NIH) - to find new ways to learn from patient data across institutions and develop new treatment approaches.

The associated PNOC Foundation, formed to support PNOC, helps fund the consortium's research and clinical trials. Allyn and Bruce Campbell, whose son was successfully treated for a brain tumor at UCSF, established the foundation in 2013. The goal was to help create a model that could more quickly move discoveries from the lab to children, regardless of where they lived.

"We want every child with brain cancer to have access to the best treatments possible and not only survive but thrive," said Allyn and Bruce Campbell. "With additional funding from foundations, industry, and governments, we can turn more research into real treatments for more children around the country and world."

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.